| Literature DB >> 36136889 |
Md Rafiqul Islam1,2, Mehrdad Shahmohammadi Beni3,4, Akihito Inamura1, Nursel Şafakattı1, Masayasu Miyake3, Mahabubur Rahman5, Abul Kalam Fazlul Haque3,6, Shigeki Ito7, Shinichi Gotoh8, Taiga Yamaya9, Hiroshi Watabe1,3.
Abstract
Proton irradiations are highly sensitive to spatial variations, mainly due to their high linear energy transfer (LET) and densely ionizing nature. In realistic clinical applications, the targets of ionizing radiation are inhomogeneous in terms of geometry and chemical composition (i.e., organs in the human body). One of the main methods for proton range monitoring is to utilize the production of proton induced positron emitting radionuclides; these could be measured precisely with positron emission tomography (PET) systems. One main positron emitting radionuclide that could be used for proton range monitoring and verification was found to be 13N that produces a peak close to the Bragg peak. In the present work, we have employed the Monte Carlo method and Spectral Analysis (SA) technique to investigate the feasibility of utilizing the 13N peak for proton range monitoring and verification in inhomogeneous targets. Two different phantom types, namely, (1) ordinary slab and (2) MIRD anthropomorphic phantoms, were used. We have found that the generated 13N peak in such highly inhomogeneous targets (ordinary slab and human phantom) is close to the actual Bragg peak, when irradiated by incident proton beam. The feasibility of using the SA technique to estimate the distribution of positron emitter was also investigated. The current findings and the developed tools in the present work would be helpful in proton range monitoring and verification in realistic clinical radiation therapy using proton beams.Entities:
Keywords: Monte Carlo method; PET; inhomogeneous targets; positron emission tomography; proton range monitoring; proton therapy
Mesh:
Substances:
Year: 2022 PMID: 36136889 PMCID: PMC9498793 DOI: 10.3390/tomography8050193
Source DB: PubMed Journal: Tomography ISSN: 2379-1381
Densities and materials composition (shown in weight percent) of the ordinary slab phantom.
| Material | Density (g·cm−3) | 1H | 12C | 14N | 16O | 23Na | 24Mg | 31P | 32S | 40Ca |
|---|---|---|---|---|---|---|---|---|---|---|
| Water | 1.000 | 11.10 | - | - | 88.90 | - | - | - | - | - |
| PMMA | 1.180 | 8.050 | 59.99 | - | 31.96 | - | - | - | - | - |
| Lung equivalent | 0.2600 | 10.30 | 10.50 | 3.100 | 74.90 | 0.2000 | - | 0.2000 | 0.3000 | - |
| Bone equivalent | 1.8500 | 3.400 | 15.50 | 4.200 | 43.50 | 0.1000 | 0.1000 | 10.30 | 0.3000 | 22.50 |
Figure 1Schematic representation of modelled ordinary slab phantom with dimensions.
Figure 2The modelled MRID anthropomorphic phantom with tumor location marked. The irradiation of the spherical tumor placed at left lung is also shown with a 10 × 10 mm2 field size.
Densities and materials composition (shown in weight percent) of the MIRD anthropomorphic phantom.
| Material | Density (g·cm−3) | 1H | 12C | 14N | 16O | Other Elements |
|---|---|---|---|---|---|---|
| Skin | 1.090 | 10.00 | 20.40 | 4.200 | 64.50 | 0.2Na, 0.1P, 0.2S, 0.3Cl, 0.1K |
| Soft tissue | 1.030 | 10.50 | 25.60 | 2.700 | 60.20 | 0.1Na, 0.2P, 0.3S, 0.2Cl, 0.2K |
| Heart | 1.050 | 10.40 | 13.90 | 2.900 | 71.80 | 0.1Na, 0.2P, 0.2S, 0.2Cl, 0.3K |
| Blood | 1.060 | 10.20 | 11.00 | 3.300 | 74.50 | 0.1Na, 0.1P, 0.2S, 0.3Cl, 0.3K, 0.1Fe |
| Lung | 0.2600 | 10.30 | 10.50 | 3.100 | 74.90 | 0.2Na, 0.2P, 0.3S, 0.3Cl, 0.2K |
| Ribs | 1.410 | 6.400 | 26.30 | 3.900 | 43.60 | 0.1Na, 0.1Mg, 6.0P, 0.3S, 0.1Cl, 0.1K, 13.1Ca |
Figure 3An illustration of the four regions of interest (ROIs) and their height (h), width (w) and depth (d) values used in SA technique.
Figure 4The 1D and 2D profiles of the simulated depth-dose of protons and production of positron emitting radionuclides (15O, 11C and 13N) in ordinary slab phantom for (a) pristine and (b) SOBP incident proton beams.
Figure 5The energy deposition (top-left) and production of positron emitting radionuclides (top-right) obtained in the modelled MIRD anthropomorphic phantom. The 2D distribution of: (a) dose deposition of protons; (b) distributions of positron emitting radionuclides determined along the incident proton beam track; and (c) the distribution of deposited dose and positron emitting radionuclides versus depth in the body of MIRD anthropomorphic phantom.
Figure 6The 2D and 1D time-course activity analysis in the time range of 15 to 55 min for 15O, 11C, and 13N positron emitting radionuclides in the ordinary slab phantom irradiated with (a) pristine and (b) SOBP beams.
Figure 7The 2D and 1D time-course activity analysis in the time range of 15 to 55 min for 15O, 11C, and 13N positron emitting radionuclides in the MIRD anthropomorphic phantom irradiated 80 MeV monoenergetic proton beam.
Figure 8The results of spectral analysis (SA) for different ROIs. Pink shows no radioisotope component, blue shows 15O, magenta shows 11C and green shows 13N positron emitting radionuclides components for: (a) ordinary slab phantom irradiated with pristine beam; (b) ordinary slab phantom irradiated with SOBP beam; and (c) for MIRD anthropomorphic phantom irradiated with 80 MeV monoenergetic beam.
Figure 9The activity of positron emitting radionuclides obtained from MC and SA methods for: (a) ordinary slab phantom irradiated with pristine beam; (b) ordinary slab phantom irradiated with SOBP beam; and (c) for MIRD anthropomorphic phantom irradiated with 80 MeV monoenergetic beam.